136 related articles for article (PubMed ID: 32845418)
1. ASO Author Reflections: Tumor Sidedness in CRS/IPC.
Yuval JB; Adileh M; Cercek A; Nash GM
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):907-908. PubMed ID: 32845418
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Venous Thromboembolism after CRS/HIPEC.
Baumgartner JM; Khan S
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):758-759. PubMed ID: 31576472
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Is CRS/HIPEC an Indication to Divert Rectal Anastomosis?
Baron E; Gushchin V; King MC; Sardi A
Ann Surg Oncol; 2020 Dec; 27(13):4941-4942. PubMed ID: 32462527
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Intraoperative Fluid Restriction During CRS-HIPEC-Less is More.
Hendrix RJ; Lambert LA
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):575-576. PubMed ID: 30838480
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Long-Term Survival Is Feasible After Complete CRS/HIPEC for Biphasic Peritoneal Mesothelioma.
Chouliaras K; Votanopoulos KI
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):770-771. PubMed ID: 30421064
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: PCI is Not Predictive of Survival After Complete CRS/HIPEC for High-Grade Appendiceal Primaries.
Chouliaras K; Votanopoulos KI
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):769. PubMed ID: 30421048
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: To Redo or Not to Redo, That is the Question: Assessing the Slings and Arrows of Repeat CRS/HIPEC in Patients with Recurrent or Progressive Peritoneal Carcinomatosis.
Powers BD; Dineen SP
Ann Surg Oncol; 2020 Dec; 27(13):4892-4893. PubMed ID: 32318947
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: A Novel Tool to Assess and Describe HIPEC Complications.
Dumitra S; Lee B
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):557-558. PubMed ID: 30600405
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Time to Change: Redefining "Complete Cytoreduction" in Appendiceal Carcinomatosis.
Munoz-Zuluaga C; King MC; Gushchin V; Sardi A
Ann Surg Oncol; 2020 Dec; 27(13):5037-5038. PubMed ID: 32935268
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis.
Baumgartner JM; Kurzrock R
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):772-773. PubMed ID: 30421042
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC.
Arjona-Sanchez A; Rodriguez-Ortiz L
Ann Surg Oncol; 2019 Aug; 26(8):2605-2606. PubMed ID: 31004296
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Characterizing the Peritoneal Immune Response to the Surgical and Thermal Trauma of Peritoneal Cytoreduction and HIPEC.
Franko J; Ferrel B; Gorvet M
Ann Surg Oncol; 2020 Dec; 27(13):5014-5015. PubMed ID: 32720041
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Developing Next-Generation Intraperitoneal Chemotherapy.
Taibi A; Sgarbura O; Hübner M
Ann Surg Oncol; 2021 Jul; 28(7):3861-3862. PubMed ID: 33216262
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Predicting Hyperthermia and Its Effect in Patients with Peritoneal Surface Malignancies.
Guerra-Londono CE; Owusu-Agyemang P; Corrales G; Rofaeil MM; Feng L; Fournier K; Cata JP
Ann Surg Oncol; 2022 Mar; 29(3):2100-2101. PubMed ID: 34713370
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Pathologic Classification of Pseudomyxoma Peritonei.
Baratti D
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):844-845. PubMed ID: 30324483
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases.
Sluiter NR; Tuynman JB
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):840-841. PubMed ID: 30302638
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Safety of Abdominal Surgical Cytoreduction Combined with Locoregional Chemohyperthermia.
Piso P
Ann Surg Oncol; 2019 Jan; 26(1):155. PubMed ID: 30478632
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer.
Sammartino P; Cornali T
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):882-883. PubMed ID: 30288653
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Disparities in Access to Cytoreductive Surgery.
Goldberg EM; Eng OS
Ann Surg Oncol; 2021 Nov; 28(12):7807-7808. PubMed ID: 34013481
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Can Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy be Improved?
Graf W; Birgisson H
Ann Surg Oncol; 2020 Jan; 27(1):301-302. PubMed ID: 31520210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
